PT  - JOURNAL ARTICLE
AU  - Marissa B. Reitsma
AU  - Sherri Rose
AU  - Alex Reinhart
AU  - Jeremy D. Goldhaber-Fiebert
AU  - Joshua A. Salomon
TI  - Bias-adjusted predictions of county-level vaccination coverage from the COVID-19 Trends and Impact Survey
AID  - 10.1101/2022.05.18.22275217
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.05.18.22275217
4099  - http://medrxiv.org/content/early/2022/05/21/2022.05.18.22275217.short
4100  - http://medrxiv.org/content/early/2022/05/21/2022.05.18.22275217.full
AB  - The potential for bias in non-representative, large-scale, low-cost survey data can limit their utility for population health measurement and public health decision-making. We developed a multi-step regression framework to bias-adjust vaccination coverage predictions from the large-scale US COVID-19 Trends and Impact Survey that included post-stratification to the American Community Survey and secondary normalization to an unbiased reference indicator. As a case study, we applied this framework to generate county-level predictions of long-run vaccination coverage among children ages 5 to 11 years. Our vaccination coverage predictions suggest a low ceiling on long-term national coverage (46%), detect substantial geographic heterogeneity (ranging from 11% to 91% across counties in the US), and highlight widespread disparities in the pace of scale-up in the three months following Emergency Use Authorization of COVID-19 vaccination for 5 to 11 year-olds. Generally, our analysis demonstrates an approach to leverage differing strengths of multiple sources of information to produce estimates on the time-scale and geographic-scale necessary for proactive decision-making. The utility of large-scale, low-cost survey data for improving population health measurement is amplified when these data are combined with other representative sources of data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMBR is supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. (DGE-1656518), Stanford's Knight-Hennessy Scholars Program, and the Stanford Data Science Scholars Program. MBR, JDGF, and JAS are supported by the Stanford Clinical and Translational Science Award to Spectrum (UL1TR003142). JDGF, SR, and JAS are supported by funding from the Centers for Disease Control and Prevention and the Council of State and Territorial Epidemiologists (NU38OT000297) and by funding from the Health Equity Research Project Fund from Stanford's School of Medicine. JDGF and JAS are supported by funding from the National Institute on Drug Abuse (3R37DA01561217S1). AR is supported by an unrestricted gift from Facebook. Facebook was involved in the design and conduct of the study. No funders had a role in the analysis and interpretation of the data, writing of the manuscript, or the decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of Stanford University gave ethical approval for this work under protocol number 56018.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSurvey microdata are not publicly available because survey participants only consented to public disclosure of aggregate data, and because the legal agreement with Facebook governing operation of the survey prohibits disclosure of microdata without confidentiality protections for respondents. Deidentified microdata are available to researchers under a Data Use Agreement that protects the confidentiality of respondents. Access can be requested online (https://cmu-delphi.github.io/delphi-epidata/symptom-survey/data-access.html). Requests are reviewed by the Carnegie Mellon University Office of Sponsored Programs and Facebook Data for Good. https://cmu-delphi.github.io/delphi-epidata/symptom-survey/data-access.html